Sona Nanotech (SONA) Stock Overview

Sona Nanotech Inc., a nanotechnology life sciences company, engages in developing various rapid diagnostic tests. Its products and services include COVID-19 Saliva Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in saliva specimens from individuals, who are suspected of COVID-19; Gemini gold nanorods; and contract services. The company is also involved in developing pre-clinical targeted hyperthermia therapy for colorectal cancer. Sona Nanotech Inc. was founded in 2014 and is based in Halifax, Canada.